课题基金 / 基金详情

Investigating Vaccinia virus-host interactions to develop a cancer-selective virotherapy

Investigating Vaccinia virus-host interactions to develop a cancer-selective virotherapy
研究痘苗病毒与宿主的相互作用以开发癌症选择性病毒疗法
批准号:
454657
负责人:
Pelin Adrian
金额:
$10.93万
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-10-01 至 2024-10-01

项目摘要

项目成果

Pelin Adrian的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Engineered oncolytic viruses (OVs) are a novel class of anti-cancer bio-therapeutics shown to preferentially replicate in the tumor microenvironment, lyse cancer cells and release neoantigens. Vaccinia virus-derived OVs have advanced to Phase III clinical
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Large genomic deletions of a novel oncolytic Vaccinia Virus increase safety, efficacy and cancer immunogenicity
Large genomic deletions of a novel oncolytic Vaccinia Virus increase safety, efficacy and cancer immunogenicity
Evaluating various Vaccinia virus strains as oncolytic engines through Next Generation Sequencing of co-infections
国内基金
海外基金
中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
  • 批准号:
    81673007
  • 项目类别:
    面上项目
  • 资助金额:
    54.0万元
  • 批准年份:
    2016
  • 负责人:
    金时
  • 依托单位: